← Leaderboards
Jonathan D Schwartz
Mount Sinai School Of Medicine Of Nyu
$668,655
Attributed
$668,655
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$668,655 · 1
By mechanism
K23$668,655 · 1
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Scott Laurence Friedman$20,818,456
- Savio L Woo$12,415,247
- Mitchell P Goldfarb$6,737,701
- Adrian T Ting$9,194,126
- Huachen Wei$4,132,533
Others in their field
Top investigators on “Neoplasm /Cancer Chemotherapy”
- Charles A Coltman · Southwest Oncology Group$171,655,324
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Philip J Disaia · University Of California Irvine$41,530,194
- Walter J Curran · Thomas Jefferson University$37,520,030
- Samuel A Wells · Duke University$32,148,803
- Gregory H Reaman · National Childhood Cancer Foundation$19,436,422
Research focus
Neoplasm /Cancer ChemotherapyTumor Necrosis Factor AlphaClinical Trial Phase IEnzyme InhibitorsEpidermal Growth FactorFibroblast Growth FactorGrowth Factor ReceptorsHepatocellular CarcinomaHuman SubjectHuman Therapy EvaluationInsulinlike Growth FactorMagnetic Resonance ImagingPatient Oriented ResearchProtein Tyrosine KinaseThalidomideTransforming Growth FactorsAngiogenesisVascular Endothelial Growth FactorsAntineoplasticsApoptosis
Grant awards (5)
Cytokine Inhibition in Hepatocellular Carcinoma$133,731
K23 · FY2005 · CA
Cytokine Inhibition in Hepatocellular Carcinoma$133,731
K23 · FY2004 · CA
Cytokine Inhibition in Hepatocellular Carcinoma$133,731
K23 · FY2003 · CA
Cytokine Inhibition in Hepatocellular Carcinoma$133,731
K23 · FY2002 · CA
Cytokine Inhibition in Hepatocellular Carcinoma$133,731
K23 · FY2001 · CA